Advanced Search

 

Study ID Status Title Patient Level Data
111611 Completed A randomised, double-blind, placebo-controlled study to assess the effect of oral, single dose SB-705498 in a validated intranasal capsaicin challenge model in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
111626 Completed A trial to evaluate the immunogenicity of accelerated primary vaccination with monovalent A/Indonesia/5/05 (H5N1) vaccine antigen in association with AS03 adjuvant in adults aged 18-64 Study Listed on ClinicalStudyDataRequest.com
111631 Completed A Phase III study for evaluation of immunogenicity and reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in people aged 18 years or above Study Listed on ClinicalStudyDataRequest.com
111635 Completed Clinical study in children, 6 months to 3 years of age, to assess the immunogenicity and safety of two dose levels of thimerosal-free Fluviral® vaccine, using a licensed influenza virus vaccine, Vaxigrip® as the control Study Listed on ClinicalStudyDataRequest.com
111649 Completed A randomised, double-blind study in healthy volunteers to compare the properties and characteristics of an investigational formulation of lamotrigine with placebo Study Listed on ClinicalStudyDataRequest.com
111652 Completed A study to evaluate GSK Biologicals’ candidate formulations of pneumococcal vaccines (GSK2189241A) in elderly subjects. Study Listed on ClinicalStudyDataRequest.com
111654 Completed Non-inferiority of a commercial lot of the pneumococcal vaccine GSK1024850A compared to a clinical lot. Study Listed on ClinicalStudyDataRequest.com
111662 Completed A fixed dose, dose response study for ropinirole prolonged release (PR) in patients with early stage Parkinson's Disease
111680 Completed An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Digoxin When Coadministered With Albiglutide in Healthy Adult Subjects Study Listed on ClinicalStudyDataRequest.com
111681 Completed An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Warfarin When Coadministered With Albiglutide in Healthy Adult Subjects Study Listed on ClinicalStudyDataRequest.com
111709 Completed Study in healthy children of GSK Biologicals’ DTPa-IPV/Hib-MenC-TT vaccine, GSK2197870A, co-administered with Prevenar™ as a three-dose primary vaccination course in infancy followed by a booster dose of Menitorix™ at 12 months of age Study Listed on ClinicalStudyDataRequest.com
111712 Completed Safety study of GSK Biologicals’ human papillomavirus vaccine (GSK-580299) in healthy female subjects. Study Listed on ClinicalStudyDataRequest.com
111716 Completed A Phase I, Open-label, Single Sequence, Crossover Study Evaluating the Safety and the Pharmacokinetics of Lopinavir/Ritonavir and Eltrombopag Given Alone and when Co-administered in Healthy Adult Subjects.
111718 Completed A randomized-open-label-five-period-balanced-crossover study to evaluate the relative bioavailability of an eltrombopag PfOS formulation relative to the 25 mg tablet formulation and to evaluate administration of the PfOS formulation with and separated 2 hours from a high calcium meal in HV
111729 Completed A trial to evaluate the safety & immunogenicity of investigational influenza vaccine GSK1557484A in adults 18-64 yrs of age Study Listed on ClinicalStudyDataRequest.com
111736 Completed Vaccination course in children primed and boosted with pneumococcal vaccine GSK 1024850A and in age-matched unprimed children Study Listed on ClinicalStudyDataRequest.com
111737 Completed Observer-blind safety and immunogenicity study of GlaxoSmithKline Biologicals’ influenza vaccine GSK2186877A when administered to elderly subjects. Study Listed on ClinicalStudyDataRequest.com
111738 Completed Safety and immunogenicity of the influenza vaccine GSK2186877A in the elderly Study Listed on ClinicalStudyDataRequest.com
111749 Completed Evaluation of the Quality of Life in COPD patients in Europe
111751 Completed Immunogenicity and safety of GSK Biologicals’ thimerosal-free TIV flu vaccine versus a licensed comparator in children Study Listed on ClinicalStudyDataRequest.com
111756 Completed Immunogenicity and safety of GSK Biologicals’ (pre-) pandemic influenza candidate vaccine GSK 1557484A. Study Listed on ClinicalStudyDataRequest.com
111761 Terminated Feasibility study of GlaxoSmithKline Biologicals’ GSK2202083A vaccine in healthy infants at 3, 5 and 11 months of age. Study Listed on ClinicalStudyDataRequest.com
111772 Completed A single-arm, international, multi-center trial of HuMax-CD20, a fully human monoclonal anti-CD20 antibody, in patients with Follicular Lymphoma who are refractory to rituximab as monotherapy or in combination with chemotherapy
111773 Completed A single-arm, international, multi-center trial of HuMax-CD20, a fully human monoclonal anti-CD20 antibody, in patients with B-cell Chronic Lymphocytic Leukemia who have failed fludarabine and alemtuzumab
111774 Completed An open-labeled, randomized, two-dose, parallel group trial of ofatumumab, a fully human monoclonal anti-CD20 antibody, in combination with fludarabine and cyclophosphamide, in patients with previously untreated B-cell CLL

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.